1. Home
  2. INBX vs HTCO Comparison

INBX vs HTCO Comparison

Compare INBX & HTCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • HTCO
  • Stock Information
  • Founded
  • INBX 2010
  • HTCO N/A
  • Country
  • INBX United States
  • HTCO Singapore
  • Employees
  • INBX N/A
  • HTCO 31
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • HTCO
  • Sector
  • INBX Health Care
  • HTCO
  • Exchange
  • INBX Nasdaq
  • HTCO NYSE
  • Market Cap
  • INBX 218.9M
  • HTCO 210.6M
  • IPO Year
  • INBX 2020
  • HTCO N/A
  • Fundamental
  • Price
  • INBX $13.92
  • HTCO $2.30
  • Analyst Decision
  • INBX Hold
  • HTCO
  • Analyst Count
  • INBX 1
  • HTCO 0
  • Target Price
  • INBX N/A
  • HTCO N/A
  • AVG Volume (30 Days)
  • INBX 81.4K
  • HTCO 151.6K
  • Earning Date
  • INBX 11-14-2024
  • HTCO 02-15-2025
  • Dividend Yield
  • INBX N/A
  • HTCO N/A
  • EPS Growth
  • INBX N/A
  • HTCO N/A
  • EPS
  • INBX 119.38
  • HTCO N/A
  • Revenue
  • INBX $1,568,000.00
  • HTCO $80,567,672.00
  • Revenue This Year
  • INBX N/A
  • HTCO N/A
  • Revenue Next Year
  • INBX N/A
  • HTCO N/A
  • P/E Ratio
  • INBX $0.12
  • HTCO N/A
  • Revenue Growth
  • INBX 19.24
  • HTCO N/A
  • 52 Week Low
  • INBX $10.80
  • HTCO $0.21
  • 52 Week High
  • INBX $18.95
  • HTCO $2.78
  • Technical
  • Relative Strength Index (RSI)
  • INBX 38.33
  • HTCO N/A
  • Support Level
  • INBX $14.53
  • HTCO N/A
  • Resistance Level
  • INBX $15.24
  • HTCO N/A
  • Average True Range (ATR)
  • INBX 0.72
  • HTCO 0.00
  • MACD
  • INBX -0.10
  • HTCO 0.00
  • Stochastic Oscillator
  • INBX 19.16
  • HTCO 0.00

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About HTCO CARAVELLE INTERNATIONAL GROUP

Caravelle International Group is an international operator of ocean transportation services. It is engaged in the seaborne transportation service under voyage contracts as well as vessel service for and on behalf of ship owners. The company has two operating segments namely, ocean transport and Heating business. The company derives the majority of its revenue from the Ocean transportation business. The company derives freight revenue from voyage contracts and provides vessel service.

Share on Social Networks: